AB052. A multicenter prospective exploratory phase II study of neoadjuvant bevacizumab for newly diagnosed malignant glioma.

Avastin (bevacizumab) - Roche

AB052 - Aronora

http://www.ncbi.nlm.nih.gov/pubmed/39295370

Hikaru Sasaki; Jun Takei; Keisuke Miyake; Ryota Tamura; Toshihide Tanaka; Yasuharu Akasaki; Yohei Yamamoto; Yuichi Murayama

Sep 21, 2024